SF1 and central nervous system cancer: We found an overexpression of DLGAP5, NEK2, and PBK, while the expression of SF1, PTEN, ATRX, and DAXX was downregulated in tumor tissues as compared to normal tissues of the patients with glioma (Supplementary Figure 5).